Effects of intranasal 17 beta-estradiol and raloxifene on lipid profile and fibrinogen in hypercholesterolemic postmenopausal women: A randomized, placebo-controlled clinical trial

Engin-Ustun, Yaprak; Ustun, Yusuf; Meydanli, M.; Kafkasli, Ayse

doi:10.1080/09513590601069470

Effects of intranasal 17 beta-estradiol and raloxifene on lipid profile and fibrinogen in hypercholesterolemic postmenopausal women: A randomized, placebo-controlled clinical trial

Engin-Ustun Y., Ustun Y., Meydanli M. M., Kafkasli A.

GYNECOLOGICAL ENDOCRINOLOGY, vol.22, no.12, pp.676-679, 2006 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 22 Issue: 12
Publication Date: 2006
Doi Number: 10.1080/09513590601069470
Journal Name: GYNECOLOGICAL ENDOCRINOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.676-679
Inonu University Affiliated: No

Abstract

Aim. To compare the effects of 17 beta-estradiol given intranasally (intranasal E-2) and raloxifene on serum lipid profile and fibrinogen in hypercholesterolemic postmenopausal women.